LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 20 filers reported holding LAVA THERAPEUTICS NV in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,090,814 | -26.6% | 2,074,372 | 0.0% | 0.15% | -9.3% |
| Q2 2023 | $4,210,975 | +22.3% | 2,074,372 | 0.0% | 0.16% | +8.7% |
| Q1 2023 | $3,443,458 | -65.1% | 2,074,372 | -26.3% | 0.15% | -63.0% |
| Q4 2022 | $9,856,686 | -23.4% | 2,816,196 | 0.0% | 0.40% | -19.2% |
| Q3 2022 | $12,870,000 | +59.8% | 2,816,196 | 0.0% | 0.50% | +62.0% |
| Q2 2022 | $8,054,000 | -35.0% | 2,816,196 | 0.0% | 0.31% | -20.4% |
| Q1 2022 | $12,391,000 | -20.0% | 2,816,196 | 0.0% | 0.39% | +9.9% |
| Q4 2021 | $15,489,000 | -7.1% | 2,816,196 | 0.0% | 0.35% | +21.0% |
| Q3 2021 | $16,672,000 | -45.6% | 2,816,196 | 0.0% | 0.29% | -35.8% |
| Q2 2021 | $30,640,000 | -28.6% | 2,816,196 | -0.3% | 0.45% | -25.0% |
| Q1 2021 | $42,903,000 | – | 2,824,409 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,070,558 | $5,097,126 | 0.34% |
| Bruce & Co., Inc. | 671,874 | $1,115,311 | 0.30% |
| Redmile Group, LLC | 2,074,372 | $3,443,458 | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 140,291 | $232,883 | 0.10% |
| Alpha Wave Global, LP | 119,516 | $198,397 | 0.07% |
| Artal Group S.A. | 200,000 | $332 | 0.02% |
| Cannell Capital | 17,955 | $29,805 | 0.01% |
| CANTOR FITZGERALD, L. P. | 53,299 | $88,476 | 0.00% |
| UBS OCONNOR LLC | 20,502 | $34,033 | 0.00% |
| AXA S.A. | 225,748 | $374,742 | 0.00% |